The U.S. Department of Justice said ExThera cooperated with the investigation into a failure to file adverse event notices with the Food and Drug Administration after two cancer patients who used its blood filtration systems in Antigua died shortly after returning home. The California-based company’s former chief regulatory officer has agreed to plead guilty and could serve prison time.

Tenaya Therapeutics and Alnylam Pharmaceuticals have agreed to collaborate on identifying potential new gene therapies for the treatment of cardiovascular disease. Tenaya will receive an upfront payment of $10 million, but stands to earn much more.

Back in February, several reprocessed EP and ultrasound catheters were recalled due to a risk of contamination. The FDA is now sharing additional information with the public.

In January, the Department of Education released a proposed rule seeking to simplify federal student loan repayment, including "commonsense loan caps" and "streamlining repayment options." 

The two men, Frank Incognito, 46, and Stephen Corba, 50, conspired with doctors in a scheme involving the fraudulent purchase of critical cancer and macular degeneration drugs, which were then diverted and resold for profit. The U.S. Department of Justice said the unlawful pact lasted seven years.

Dubbed Health100, the application is being launched as a subsidiary of CVS Health, utilizing Google’s cloud infrastructure data access and security. Powered by AI, Health100 is said to be a full assistant to help patients find providers, services and prescriptions, with the aim being to reduce out-of-pocket spending.

A fired employee of Nuance, a Microsoft subsidiary, is responsible for stealing records on 1.3 million patients from Geisinger Health in Pennsylvania. He has pleaded guilty as part of a deal with prosecutors.

The deal is expected to be finalized later this month once customary closing conditions are met.